Crossmark

Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis

Crossref DOI link: https://doi.org/10.1007/s12272-021-01333-7

Published Online: 2021-06-17

Published Print: 2021-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lim, Juhee

Kim, Hyo In

Bang, Yeojin

Choi, Hyun Jin https://orcid.org/0000-0002-5736-9525
Funding

Funding for this research was provided by:

National Research Foundation of Korea (NRF-2018R1A2B6004008, NRF-2019M3A9A8067070, NRF-2019R1I1A1A01063630)

Gyeonggi-do Regional Research Center (GRRC-CHA2020-A04)
License Information

Text and Data Mining valid from 2021-06-01

Version of Record valid from 2021-06-01
More Information

Article History

Received: 25 January 2021

Accepted: 25 May 2021

First Online: 17 June 2021

Declarations

:

: The authors have no conflicts of interest to disclose.

Document is current

Any future updates will be listed below